Perceptive Advisors LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-16 9:02 pm Unchanged |
2024-12-12 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 255,151 19.500% |
0 (Unchanged) |
Filing |
| 2024-08-15 6:31 pm Sale |
2024-08-14 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 255,151 19.500% |
-0 (-0.00%) |
Filing |
| 2024-02-14 4:29 pm Unchanged |
2024-02-14 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 255,151 24.300% |
0 (Unchanged) |
Filing |
| 2023-06-02 4:16 pm Purchase |
2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 255,151 25.800% |
72,217 (+39.48%) |
Filing |
| 2022-04-14 5:10 pm Purchase |
2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 182,935 24.800% |
118,483 (+183.83%) |
Filing |